PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.\', \'Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.\', \'Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Division of Clinical Informatics, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.\', \'Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: jekirby@bidmc.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0732-8893(21)00267-410.1016/j.diagmicrobio.2021.115575
?:doi
?:hasPublicationType
?:journal
  • Diagnostic microbiology and infectious disease
is ?:pmid of
?:pmid
?:pmid
  • 34839127
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.157
?:rankingScore_hIndex
  • 86
?:title
  • Verification of the Abbott Alinity m Resp-4-Plex assay for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all